Abbott extends change-in-control agreements for NEOs through Dec 2026

ABBOTT LABORATORIES

Agreements previously set to expire Dec 31, 2024, now extended to Dec 31, 2026.
Notification given to named executive officers on November 12, 2024.
Extension automatically continues term through second anniversary of original expiration date.

item 5.02

ABBOTT LABORATORIES filing history →

Source: SEC EDGAR

accession 0001104659-24-119717

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.